Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Schizophrenia and amphetamine dependence. A case report].

A Dervaux1, M-O Krebs, X Laqueille

  • 1Service de Psychiatrie, BP 27, Centre Hospitalier Général, F-91401 Orsay.

L'Encephale
|June 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Interest of the use of the "MYDEFI" smartphone application to help reduce alcohol consumption in the involvement of pharmacists in the prevention of at-risk consumption: Results of a survey in the Hauts-de-France].

Annales pharmaceutiques francaises·2022
Same author

[Opioids substitution therapy: A respect for the dignity of the human person].

L'Encephale·2021
Same author

[Validation of a French version of the 16-item Prodromal Questionnaire (fPQ16) in adolescents and young adults seeking help].

L'Encephale·2021
Same author

[Problematic gambling and criminal responsibility].

L'Encephale·2020
Same author

[Management of cardiovascular co-morbidities in young patients with early onset psychosis: State of the art and therapeutic perspectives].

L'Encephale·2020
Same author

[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]

L'Encephale·2020
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Chronic amphetamine abuse significantly worsened psychotic symptoms in a schizophrenic patient, with potential for prolonged neurotoxicity and behavioral disturbances even after withdrawal.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Amphetamine-induced psychosis is well-documented, but its impact on schizophrenia is less understood.
  • This case study examines the long-term effects of amphetamine dependence in a patient with pre-existing schizophrenia.

Observation:

  • A schizophrenic patient with a 7-year history of amphetamine abuse experienced exacerbated delusions and hallucinations.
  • Despite discontinuing amphetamines, the patient exhibited prolonged psycho-behavioral disturbances, including violent behavior.
  • Neuroleptic treatment showed moderate efficacy, with olanzapine improving negative symptoms.

Findings:

  • Amphetamine consumption led to a marked deterioration of positive psychotic symptoms, particularly persecutory delusions and hallucinations.

Related Experiment Videos

  • The patient displayed withdrawal symptoms upon amphetamine cessation.
  • Evidence suggests prolonged neurotoxicity and persistent psycho-behavioral disturbances following chronic amphetamine use.
  • Implications:

    • Amphetamine abuse can have severe and lasting consequences for individuals with schizophrenia.
    • Neurobiological and psycho-behavioral effects of amphetamines may persist long after drug withdrawal.
    • Further research is needed to understand the long-term neurotoxicity of amphetamines in psychiatric populations.